PRICE T ROWE ASSOCIATES INC /MD/ - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 95 filers reported holding ONCOCYTE CORP in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q3 2022$27,000
-18.2%
36,6000.0%0.00%
Q2 2022$33,000
-46.8%
36,600
-12.0%
0.00%
Q1 2022$62,000
+5.1%
41,578
+53.5%
0.00%
Q4 2021$59,000
-43.3%
27,078
-6.9%
0.00%
Q3 2021$104,000
-37.3%
29,078
+0.7%
0.00%
Q2 2021$166,000
-32.2%
28,878
-38.9%
0.00%
Q1 2021$245,00047,2730.00%
Other shareholders
ONCOCYTE CORP shareholders Q2 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,596,680$27,155,0004.50%
Family Management Corp 20,550$155,0000.11%
Artal Group S.A. 150,000$1,133,0000.02%
Destination Wealth Management 29,656$224,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 145,000$1,095,0000.01%
Carroll Financial Associates, Inc. 850$5,0000.00%
Advisor Group, Inc. 112$1,0000.00%
FIFTH THIRD BANCORP 210$2,0000.00%
HUNTINGTON NATIONAL BANK 10$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 2,413$18,0000.00%
View complete list of ONCOCYTE CORP shareholders